Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › β-d-2′-deoxy-2′-α-fluoro-2′-β-c-substituted-2-modified-n6-substituted purine nucleotides for HCV treatment

β-d-2′-deoxy-2′-α-fluoro-2′-β-c-substituted-2-modified-n6-substituted purine nucleotides for HCV treatment

US Patent 10875885 · Granted Dec 29, 2020

Estimated economic value: $38,385,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Advantageous anti-HCV combination therapy2025
Advantageous anti-HCV combination therapy2025
Vehicle localization system and method2025
Highly active compounds against COVID-192025
Highly active compounds against COVID-192025
Crystalline epinephrine malonate salt2024
Crystalline epinephrine malonate salt2024
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nuc2024
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nuc2024
Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus2024
Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus2024
Methods and systems to enhance pipeline trajectory reconstruction using pipeline2024